Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment

Clinical trial NCT03752489 · UNKNOWN

Trial details

NCT number: NCT03752489
Sponsor: Dascena
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Severe Sepsis Septic Shock

Start date: 2022-04-01
Primary completion: 2024-03-31
Enrollment: 51645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.